nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—CYP2C8—Mometasone—systemic scleroderma	0.154	0.201	CbGbCtD
Amprenavir—ABCB1—Lisinopril—systemic scleroderma	0.0703	0.0918	CbGbCtD
Amprenavir—CYP2C9—Leflunomide—systemic scleroderma	0.0691	0.0902	CbGbCtD
Amprenavir—ABCC1—Methotrexate—systemic scleroderma	0.0688	0.0899	CbGbCtD
Amprenavir—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0636	0.0831	CbGbCtD
Amprenavir—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0612	0.0799	CbGbCtD
Amprenavir—ABCB1—Captopril—systemic scleroderma	0.0526	0.0687	CbGbCtD
Amprenavir—CYP2D6—Captopril—systemic scleroderma	0.0496	0.0647	CbGbCtD
Amprenavir—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0414	0.0541	CbGbCtD
Amprenavir—CYP2C19—Prednisone—systemic scleroderma	0.041	0.0536	CbGbCtD
Amprenavir—ABCB1—Prednisone—systemic scleroderma	0.0331	0.0432	CbGbCtD
Amprenavir—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0248	0.0324	CbGbCtD
Amprenavir—CYP3A4—Prednisone—systemic scleroderma	0.0198	0.0259	CbGbCtD
Amprenavir—ABCB1—Methotrexate—systemic scleroderma	0.0166	0.0217	CbGbCtD
Amprenavir—Myalgia—Mometasone—systemic scleroderma	0.000857	0.00367	CcSEcCtD
Amprenavir—Hepatobiliary disease—Mycophenolic acid—systemic scleroderma	0.000841	0.0036	CcSEcCtD
Amprenavir—Liver function test abnormal—Mycophenolate mofetil—systemic scleroderma	0.000841	0.0036	CcSEcCtD
Amprenavir—Neutropenia—Lisinopril—systemic scleroderma	0.00084	0.0036	CcSEcCtD
Amprenavir—Erythema multiforme—Azathioprine—systemic scleroderma	0.000838	0.00359	CcSEcCtD
Amprenavir—Decreased appetite—Pentoxifylline—systemic scleroderma	0.000827	0.00354	CcSEcCtD
Amprenavir—Connective tissue disorder—Leflunomide—systemic scleroderma	0.000822	0.00352	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Mycophenolate mofetil—systemic scleroderma	0.00082	0.00351	CcSEcCtD
Amprenavir—Hyperglycaemia—Lisinopril—systemic scleroderma	0.00081	0.00347	CcSEcCtD
Amprenavir—Angioedema—Captopril—systemic scleroderma	0.000808	0.00346	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Mycophenolate mofetil—systemic scleroderma	0.000803	0.00344	CcSEcCtD
Amprenavir—Depression—Lisinopril—systemic scleroderma	0.000799	0.00342	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Lisinopril—systemic scleroderma	0.000794	0.0034	CcSEcCtD
Amprenavir—Erythema multiforme—Leflunomide—systemic scleroderma	0.000791	0.00339	CcSEcCtD
Amprenavir—Acute coronary syndrome—Lisinopril—systemic scleroderma	0.00079	0.00338	CcSEcCtD
Amprenavir—Myocardial infarction—Lisinopril—systemic scleroderma	0.000785	0.00336	CcSEcCtD
Amprenavir—Connective tissue disorder—Mycophenolic acid—systemic scleroderma	0.000785	0.00336	CcSEcCtD
Amprenavir—Anorexia—Mometasone—systemic scleroderma	0.000783	0.00335	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Methotrexate—systemic scleroderma	0.000782	0.00334	CcSEcCtD
Amprenavir—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.000778	0.00333	CcSEcCtD
Amprenavir—Cardiac disorder—Leflunomide—systemic scleroderma	0.000777	0.00332	CcSEcCtD
Amprenavir—Hepatobiliary disease—Lisinopril—systemic scleroderma	0.000758	0.00324	CcSEcCtD
Amprenavir—Myalgia—Captopril—systemic scleroderma	0.000753	0.00322	CcSEcCtD
Amprenavir—Abdominal pain—Pentoxifylline—systemic scleroderma	0.000752	0.00322	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.000748	0.0032	CcSEcCtD
Amprenavir—Discomfort—Captopril—systemic scleroderma	0.000744	0.00318	CcSEcCtD
Amprenavir—Cardiac disorder—Mycophenolic acid—systemic scleroderma	0.000741	0.00317	CcSEcCtD
Amprenavir—Paraesthesia—Mometasone—systemic scleroderma	0.000738	0.00316	CcSEcCtD
Amprenavir—Neutropenia—Mycophenolate mofetil—systemic scleroderma	0.000736	0.00315	CcSEcCtD
Amprenavir—Mental disorder—Leflunomide—systemic scleroderma	0.000733	0.00314	CcSEcCtD
Amprenavir—Inflammation—Methotrexate—systemic scleroderma	0.000733	0.00314	CcSEcCtD
Amprenavir—Malnutrition—Leflunomide—systemic scleroderma	0.000729	0.00312	CcSEcCtD
Amprenavir—Flatulence—Leflunomide—systemic scleroderma	0.000718	0.00307	CcSEcCtD
Amprenavir—Decreased appetite—Mometasone—systemic scleroderma	0.000714	0.00306	CcSEcCtD
Amprenavir—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.00071	0.00304	CcSEcCtD
Amprenavir—Diabetes mellitus—Prednisone—systemic scleroderma	0.00071	0.00304	CcSEcCtD
Amprenavir—Fatigue—Mometasone—systemic scleroderma	0.000708	0.00303	CcSEcCtD
Amprenavir—Depression—Mycophenolate mofetil—systemic scleroderma	0.0007	0.00299	CcSEcCtD
Amprenavir—Mental disorder—Mycophenolic acid—systemic scleroderma	0.000699	0.00299	CcSEcCtD
Amprenavir—Malnutrition—Mycophenolic acid—systemic scleroderma	0.000695	0.00297	CcSEcCtD
Amprenavir—Acute coronary syndrome—Mycophenolate mofetil—systemic scleroderma	0.000692	0.00296	CcSEcCtD
Amprenavir—Myocardial infarction—Mycophenolate mofetil—systemic scleroderma	0.000688	0.00294	CcSEcCtD
Amprenavir—Anorexia—Captopril—systemic scleroderma	0.000688	0.00294	CcSEcCtD
Amprenavir—Flatulence—Mycophenolic acid—systemic scleroderma	0.000685	0.00293	CcSEcCtD
Amprenavir—Asthenia—Pentoxifylline—systemic scleroderma	0.000683	0.00292	CcSEcCtD
Amprenavir—Erythema multiforme—Lisinopril—systemic scleroderma	0.00068	0.00291	CcSEcCtD
Amprenavir—Pruritus—Pentoxifylline—systemic scleroderma	0.000673	0.00288	CcSEcCtD
Amprenavir—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000672	0.00287	CcSEcCtD
Amprenavir—Angioedema—Leflunomide—systemic scleroderma	0.000666	0.00285	CcSEcCtD
Amprenavir—Hepatobiliary disease—Mycophenolate mofetil—systemic scleroderma	0.000664	0.00284	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.000657	0.00281	CcSEcCtD
Amprenavir—Myalgia—Azathioprine—systemic scleroderma	0.000657	0.00281	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.000652	0.00279	CcSEcCtD
Amprenavir—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000651	0.00279	CcSEcCtD
Amprenavir—Tremor—Mycophenolic acid—systemic scleroderma	0.000651	0.00279	CcSEcCtD
Amprenavir—Abdominal pain—Mometasone—systemic scleroderma	0.000649	0.00278	CcSEcCtD
Amprenavir—Discomfort—Azathioprine—systemic scleroderma	0.000649	0.00278	CcSEcCtD
Amprenavir—Paraesthesia—Captopril—systemic scleroderma	0.000648	0.00277	CcSEcCtD
Amprenavir—Mental disorder—Lisinopril—systemic scleroderma	0.00063	0.0027	CcSEcCtD
Amprenavir—Decreased appetite—Captopril—systemic scleroderma	0.000627	0.00268	CcSEcCtD
Amprenavir—Malnutrition—Lisinopril—systemic scleroderma	0.000626	0.00268	CcSEcCtD
Amprenavir—Fatigue—Captopril—systemic scleroderma	0.000622	0.00266	CcSEcCtD
Amprenavir—Myalgia—Leflunomide—systemic scleroderma	0.00062	0.00265	CcSEcCtD
Amprenavir—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.000619	0.00265	CcSEcCtD
Amprenavir—Flatulence—Lisinopril—systemic scleroderma	0.000617	0.00264	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.000616	0.00264	CcSEcCtD
Amprenavir—Discomfort—Leflunomide—systemic scleroderma	0.000613	0.00262	CcSEcCtD
Amprenavir—Skin disorder—Azathioprine—systemic scleroderma	0.000612	0.00262	CcSEcCtD
Amprenavir—Vomiting—Pentoxifylline—systemic scleroderma	0.000605	0.00259	CcSEcCtD
Amprenavir—Rash—Pentoxifylline—systemic scleroderma	0.0006	0.00257	CcSEcCtD
Amprenavir—Dermatitis—Pentoxifylline—systemic scleroderma	0.0006	0.00257	CcSEcCtD
Amprenavir—Headache—Pentoxifylline—systemic scleroderma	0.000596	0.00255	CcSEcCtD
Amprenavir—Diabetes mellitus—Methotrexate—systemic scleroderma	0.000593	0.00254	CcSEcCtD
Amprenavir—Myalgia—Mycophenolic acid—systemic scleroderma	0.000592	0.00253	CcSEcCtD
Amprenavir—Gastrointestinal pain—Captopril—systemic scleroderma	0.00059	0.00252	CcSEcCtD
Amprenavir—Asthenia—Mometasone—systemic scleroderma	0.000589	0.00252	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000588	0.00251	CcSEcCtD
Amprenavir—Tremor—Lisinopril—systemic scleroderma	0.000586	0.00251	CcSEcCtD
Amprenavir—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000585	0.0025	CcSEcCtD
Amprenavir—Discomfort—Mycophenolic acid—systemic scleroderma	0.000585	0.0025	CcSEcCtD
Amprenavir—Nervous system disorder—Leflunomide—systemic scleroderma	0.000583	0.0025	CcSEcCtD
Amprenavir—Pruritus—Mometasone—systemic scleroderma	0.000581	0.00249	CcSEcCtD
Amprenavir—Skin disorder—Leflunomide—systemic scleroderma	0.000578	0.00247	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000574	0.00245	CcSEcCtD
Amprenavir—Angioedema—Lisinopril—systemic scleroderma	0.000572	0.00245	CcSEcCtD
Amprenavir—Abdominal pain—Captopril—systemic scleroderma	0.00057	0.00244	CcSEcCtD
Amprenavir—Anorexia—Leflunomide—systemic scleroderma	0.000567	0.00243	CcSEcCtD
Amprenavir—Nausea—Pentoxifylline—systemic scleroderma	0.000565	0.00242	CcSEcCtD
Amprenavir—Diarrhoea—Mometasone—systemic scleroderma	0.000562	0.0024	CcSEcCtD
Amprenavir—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000556	0.00238	CcSEcCtD
Amprenavir—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000552	0.00236	CcSEcCtD
Amprenavir—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000551	0.00236	CcSEcCtD
Amprenavir—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000548	0.00235	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.000544	0.00233	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000544	0.00233	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000542	0.00232	CcSEcCtD
Amprenavir—Anorexia—Mycophenolic acid—systemic scleroderma	0.000541	0.00231	CcSEcCtD
Amprenavir—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00054	0.00231	CcSEcCtD
Amprenavir—Paraesthesia—Leflunomide—systemic scleroderma	0.000534	0.00228	CcSEcCtD
Amprenavir—Myalgia—Lisinopril—systemic scleroderma	0.000533	0.00228	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000529	0.00226	CcSEcCtD
Amprenavir—Discomfort—Lisinopril—systemic scleroderma	0.000527	0.00225	CcSEcCtD
Amprenavir—Vomiting—Mometasone—systemic scleroderma	0.000522	0.00223	CcSEcCtD
Amprenavir—Rash—Mometasone—systemic scleroderma	0.000518	0.00222	CcSEcCtD
Amprenavir—Asthenia—Captopril—systemic scleroderma	0.000518	0.00221	CcSEcCtD
Amprenavir—Dermatitis—Mometasone—systemic scleroderma	0.000517	0.00221	CcSEcCtD
Amprenavir—Decreased appetite—Leflunomide—systemic scleroderma	0.000517	0.00221	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000517	0.00221	CcSEcCtD
Amprenavir—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000515	0.0022	CcSEcCtD
Amprenavir—Headache—Mometasone—systemic scleroderma	0.000515	0.0022	CcSEcCtD
Amprenavir—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000514	0.0022	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000513	0.0022	CcSEcCtD
Amprenavir—Fatigue—Leflunomide—systemic scleroderma	0.000513	0.00219	CcSEcCtD
Amprenavir—Pruritus—Captopril—systemic scleroderma	0.00051	0.00218	CcSEcCtD
Amprenavir—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000509	0.00218	CcSEcCtD
Amprenavir—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000501	0.00214	CcSEcCtD
Amprenavir—Neutropenia—Prednisone—systemic scleroderma	0.000499	0.00214	CcSEcCtD
Amprenavir—Abdominal pain—Azathioprine—systemic scleroderma	0.000498	0.00213	CcSEcCtD
Amprenavir—Skin disorder—Lisinopril—systemic scleroderma	0.000496	0.00212	CcSEcCtD
Amprenavir—Diarrhoea—Captopril—systemic scleroderma	0.000494	0.00211	CcSEcCtD
Amprenavir—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000493	0.00211	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00049	0.0021	CcSEcCtD
Amprenavir—Fatigue—Mycophenolic acid—systemic scleroderma	0.000489	0.00209	CcSEcCtD
Amprenavir—Nausea—Mometasone—systemic scleroderma	0.000488	0.00209	CcSEcCtD
Amprenavir—Anorexia—Lisinopril—systemic scleroderma	0.000487	0.00208	CcSEcCtD
Amprenavir—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000486	0.00208	CcSEcCtD
Amprenavir—Hyperglycaemia—Prednisone—systemic scleroderma	0.000481	0.00206	CcSEcCtD
Amprenavir—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000476	0.00204	CcSEcCtD
Amprenavir—Depression—Prednisone—systemic scleroderma	0.000474	0.00203	CcSEcCtD
Amprenavir—Abdominal pain—Leflunomide—systemic scleroderma	0.00047	0.00201	CcSEcCtD
Amprenavir—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000469	0.00201	CcSEcCtD
Amprenavir—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000467	0.002	CcSEcCtD
Amprenavir—Myocardial infarction—Prednisone—systemic scleroderma	0.000466	0.002	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000465	0.00199	CcSEcCtD
Amprenavir—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000464	0.00198	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000464	0.00198	CcSEcCtD
Amprenavir—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000461	0.00197	CcSEcCtD
Amprenavir—Paraesthesia—Lisinopril—systemic scleroderma	0.000459	0.00196	CcSEcCtD
Amprenavir—Vomiting—Captopril—systemic scleroderma	0.000459	0.00196	CcSEcCtD
Amprenavir—Rash—Captopril—systemic scleroderma	0.000455	0.00195	CcSEcCtD
Amprenavir—Dermatitis—Captopril—systemic scleroderma	0.000454	0.00194	CcSEcCtD
Amprenavir—Headache—Captopril—systemic scleroderma	0.000452	0.00193	CcSEcCtD
Amprenavir—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000448	0.00192	CcSEcCtD
Amprenavir—Decreased appetite—Lisinopril—systemic scleroderma	0.000444	0.0019	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000441	0.00189	CcSEcCtD
Amprenavir—Fatigue—Lisinopril—systemic scleroderma	0.00044	0.00188	CcSEcCtD
Amprenavir—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000439	0.00188	CcSEcCtD
Amprenavir—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000435	0.00186	CcSEcCtD
Amprenavir—Diarrhoea—Azathioprine—systemic scleroderma	0.000431	0.00184	CcSEcCtD
Amprenavir—Nausea—Captopril—systemic scleroderma	0.000429	0.00183	CcSEcCtD
Amprenavir—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000427	0.00183	CcSEcCtD
Amprenavir—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000427	0.00183	CcSEcCtD
Amprenavir—Asthenia—Leflunomide—systemic scleroderma	0.000427	0.00183	CcSEcCtD
Amprenavir—Pruritus—Leflunomide—systemic scleroderma	0.000421	0.0018	CcSEcCtD
Amprenavir—Connective tissue disorder—Prednisone—systemic scleroderma	0.00042	0.0018	CcSEcCtD
Amprenavir—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000418	0.00179	CcSEcCtD
Amprenavir—Neutropenia—Methotrexate—systemic scleroderma	0.000417	0.00178	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000408	0.00175	CcSEcCtD
Amprenavir—Asthenia—Mycophenolic acid—systemic scleroderma	0.000407	0.00174	CcSEcCtD
Amprenavir—Diarrhoea—Leflunomide—systemic scleroderma	0.000407	0.00174	CcSEcCtD
Amprenavir—Abdominal pain—Lisinopril—systemic scleroderma	0.000404	0.00173	CcSEcCtD
Amprenavir—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000402	0.00172	CcSEcCtD
Amprenavir—Pruritus—Mycophenolic acid—systemic scleroderma	0.000401	0.00172	CcSEcCtD
Amprenavir—Vomiting—Azathioprine—systemic scleroderma	0.0004	0.00171	CcSEcCtD
Amprenavir—Rash—Azathioprine—systemic scleroderma	0.000397	0.0017	CcSEcCtD
Amprenavir—Dermatitis—Azathioprine—systemic scleroderma	0.000397	0.0017	CcSEcCtD
Amprenavir—Depression—Methotrexate—systemic scleroderma	0.000396	0.0017	CcSEcCtD
Amprenavir—Headache—Azathioprine—systemic scleroderma	0.000394	0.00169	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000394	0.00169	CcSEcCtD
Amprenavir—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000389	0.00167	CcSEcCtD
Amprenavir—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000388	0.00166	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000386	0.00165	CcSEcCtD
Amprenavir—Vomiting—Leflunomide—systemic scleroderma	0.000378	0.00162	CcSEcCtD
Amprenavir—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000376	0.00161	CcSEcCtD
Amprenavir—Rash—Leflunomide—systemic scleroderma	0.000375	0.0016	CcSEcCtD
Amprenavir—Dermatitis—Leflunomide—systemic scleroderma	0.000375	0.0016	CcSEcCtD
Amprenavir—Mental disorder—Prednisone—systemic scleroderma	0.000374	0.0016	CcSEcCtD
Amprenavir—Nausea—Azathioprine—systemic scleroderma	0.000374	0.0016	CcSEcCtD
Amprenavir—Headache—Leflunomide—systemic scleroderma	0.000372	0.00159	CcSEcCtD
Amprenavir—Malnutrition—Prednisone—systemic scleroderma	0.000372	0.00159	CcSEcCtD
Amprenavir—CYP2C9—cardial valve—systemic scleroderma	0.00037	0.629	CbGeAlD
Amprenavir—Asthenia—Lisinopril—systemic scleroderma	0.000367	0.00157	CcSEcCtD
Amprenavir—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000366	0.00157	CcSEcCtD
Amprenavir—Pruritus—Lisinopril—systemic scleroderma	0.000361	0.00155	CcSEcCtD
Amprenavir—Vomiting—Mycophenolic acid—systemic scleroderma	0.000361	0.00154	CcSEcCtD
Amprenavir—Rash—Mycophenolic acid—systemic scleroderma	0.000358	0.00153	CcSEcCtD
Amprenavir—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000357	0.00153	CcSEcCtD
Amprenavir—Headache—Mycophenolic acid—systemic scleroderma	0.000355	0.00152	CcSEcCtD
Amprenavir—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000354	0.00151	CcSEcCtD
Amprenavir—Nausea—Leflunomide—systemic scleroderma	0.000353	0.00151	CcSEcCtD
Amprenavir—Diarrhoea—Lisinopril—systemic scleroderma	0.00035	0.0015	CcSEcCtD
Amprenavir—Angioedema—Prednisone—systemic scleroderma	0.00034	0.00145	CcSEcCtD
Amprenavir—Erythema multiforme—Methotrexate—systemic scleroderma	0.000337	0.00144	CcSEcCtD
Amprenavir—Nausea—Mycophenolic acid—systemic scleroderma	0.000337	0.00144	CcSEcCtD
Amprenavir—Cardiac disorder—Methotrexate—systemic scleroderma	0.000331	0.00142	CcSEcCtD
Amprenavir—Vomiting—Lisinopril—systemic scleroderma	0.000325	0.00139	CcSEcCtD
Amprenavir—Rash—Lisinopril—systemic scleroderma	0.000322	0.00138	CcSEcCtD
Amprenavir—Dermatitis—Lisinopril—systemic scleroderma	0.000322	0.00138	CcSEcCtD
Amprenavir—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000321	0.00137	CcSEcCtD
Amprenavir—Headache—Lisinopril—systemic scleroderma	0.00032	0.00137	CcSEcCtD
Amprenavir—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000317	0.00136	CcSEcCtD
Amprenavir—Myalgia—Prednisone—systemic scleroderma	0.000317	0.00135	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000314	0.00135	CcSEcCtD
Amprenavir—Discomfort—Prednisone—systemic scleroderma	0.000313	0.00134	CcSEcCtD
Amprenavir—Mental disorder—Methotrexate—systemic scleroderma	0.000313	0.00134	CcSEcCtD
Amprenavir—Malnutrition—Methotrexate—systemic scleroderma	0.000311	0.00133	CcSEcCtD
Amprenavir—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000306	0.00131	CcSEcCtD
Amprenavir—Nausea—Lisinopril—systemic scleroderma	0.000303	0.0013	CcSEcCtD
Amprenavir—Nervous system disorder—Prednisone—systemic scleroderma	0.000298	0.00127	CcSEcCtD
Amprenavir—Skin disorder—Prednisone—systemic scleroderma	0.000295	0.00126	CcSEcCtD
Amprenavir—Anorexia—Prednisone—systemic scleroderma	0.000289	0.00124	CcSEcCtD
Amprenavir—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000285	0.00122	CcSEcCtD
Amprenavir—Rash—Mycophenolate mofetil—systemic scleroderma	0.000282	0.00121	CcSEcCtD
Amprenavir—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000282	0.00121	CcSEcCtD
Amprenavir—Headache—Mycophenolate mofetil—systemic scleroderma	0.00028	0.0012	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000276	0.00118	CcSEcCtD
Amprenavir—Paraesthesia—Prednisone—systemic scleroderma	0.000272	0.00117	CcSEcCtD
Amprenavir—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000266	0.00114	CcSEcCtD
Amprenavir—Myalgia—Methotrexate—systemic scleroderma	0.000265	0.00113	CcSEcCtD
Amprenavir—Decreased appetite—Prednisone—systemic scleroderma	0.000264	0.00113	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000263	0.00112	CcSEcCtD
Amprenavir—Fatigue—Prednisone—systemic scleroderma	0.000262	0.00112	CcSEcCtD
Amprenavir—Discomfort—Methotrexate—systemic scleroderma	0.000261	0.00112	CcSEcCtD
Amprenavir—Nervous system disorder—Methotrexate—systemic scleroderma	0.000249	0.00106	CcSEcCtD
Amprenavir—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000248	0.00106	CcSEcCtD
Amprenavir—Skin disorder—Methotrexate—systemic scleroderma	0.000246	0.00105	CcSEcCtD
Amprenavir—Anorexia—Methotrexate—systemic scleroderma	0.000242	0.00103	CcSEcCtD
Amprenavir—Abdominal pain—Prednisone—systemic scleroderma	0.00024	0.00103	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000231	0.000989	CcSEcCtD
Amprenavir—Paraesthesia—Methotrexate—systemic scleroderma	0.000228	0.000974	CcSEcCtD
Amprenavir—Decreased appetite—Methotrexate—systemic scleroderma	0.00022	0.000943	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000219	0.000937	CcSEcCtD
Amprenavir—Fatigue—Methotrexate—systemic scleroderma	0.000219	0.000936	CcSEcCtD
Amprenavir—Asthenia—Prednisone—systemic scleroderma	0.000218	0.000932	CcSEcCtD
Amprenavir—Pruritus—Prednisone—systemic scleroderma	0.000215	0.000919	CcSEcCtD
Amprenavir—Diarrhoea—Prednisone—systemic scleroderma	0.000208	0.000888	CcSEcCtD
Amprenavir—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000207	0.000887	CcSEcCtD
Amprenavir—Abdominal pain—Methotrexate—systemic scleroderma	0.0002	0.000858	CcSEcCtD
Amprenavir—Vomiting—Prednisone—systemic scleroderma	0.000193	0.000826	CcSEcCtD
Amprenavir—Rash—Prednisone—systemic scleroderma	0.000191	0.000819	CcSEcCtD
Amprenavir—Dermatitis—Prednisone—systemic scleroderma	0.000191	0.000818	CcSEcCtD
Amprenavir—Headache—Prednisone—systemic scleroderma	0.00019	0.000813	CcSEcCtD
Amprenavir—Asthenia—Methotrexate—systemic scleroderma	0.000182	0.000779	CcSEcCtD
Amprenavir—Nausea—Prednisone—systemic scleroderma	0.00018	0.000771	CcSEcCtD
Amprenavir—Pruritus—Methotrexate—systemic scleroderma	0.000179	0.000768	CcSEcCtD
Amprenavir—Diarrhoea—Methotrexate—systemic scleroderma	0.000174	0.000742	CcSEcCtD
Amprenavir—Vomiting—Methotrexate—systemic scleroderma	0.000161	0.00069	CcSEcCtD
Amprenavir—Rash—Methotrexate—systemic scleroderma	0.00016	0.000684	CcSEcCtD
Amprenavir—Dermatitis—Methotrexate—systemic scleroderma	0.00016	0.000684	CcSEcCtD
Amprenavir—Headache—Methotrexate—systemic scleroderma	0.000159	0.00068	CcSEcCtD
Amprenavir—Nausea—Methotrexate—systemic scleroderma	0.000151	0.000645	CcSEcCtD
Amprenavir—ABCB1—blood vessel—systemic scleroderma	2.33e-05	0.0397	CbGeAlD
Amprenavir—CYP2C19—digestive system—systemic scleroderma	2.06e-05	0.0351	CbGeAlD
Amprenavir—CYP2B6—skin of body—systemic scleroderma	2.02e-05	0.0344	CbGeAlD
Amprenavir—ABCC1—tendon—systemic scleroderma	2.01e-05	0.0343	CbGeAlD
Amprenavir—ABCC1—lung—systemic scleroderma	1.77e-05	0.0301	CbGeAlD
Amprenavir—CYP3A5—digestive system—systemic scleroderma	1.63e-05	0.0277	CbGeAlD
Amprenavir—CYP2B6—digestive system—systemic scleroderma	1.62e-05	0.0275	CbGeAlD
Amprenavir—CYP2C9—digestive system—systemic scleroderma	1.6e-05	0.0272	CbGeAlD
Amprenavir—CYP3A5—lung—systemic scleroderma	1.36e-05	0.0231	CbGeAlD
Amprenavir—CYP2B6—lung—systemic scleroderma	1.35e-05	0.023	CbGeAlD
Amprenavir—CYP3A4—digestive system—systemic scleroderma	1.22e-05	0.0208	CbGeAlD
Amprenavir—CYP2D6—digestive system—systemic scleroderma	1.2e-05	0.0204	CbGeAlD
Amprenavir—ABCB1—digestive system—systemic scleroderma	8.64e-06	0.0147	CbGeAlD
Amprenavir—ABCB1—lung—systemic scleroderma	7.22e-06	0.0123	CbGeAlD
